CMS Issues Interim Final Rule Establishing New COVID Treatment Add-On Payment

Original story posted on: December 21, 2020

Comments are being sought now.

With two COVID-19 vaccines now being distributed nationwide and more on the way, in addition to what are sure to be forthcoming enhancements in treatment of the virus, federal officials have issued an interim final rule with comment period establishing add-on payments for such measures.  

The Centers for Medicare & Medicaid Services (CMS) issued an MLN Connects Special Edition post about the New COVID-19 Treatments Add-on Payment (NCTAP) under the Inpatient Prospective Payment System (IPPS) on Monday, noting that the payments will remain in effect retroactively from Nov. 2, 2020 through the termination of the federally declared COVID public health emergency (PHE).

“To mitigate potential financial disincentives for hospitals to provide new COVID-19 treatments during the COVID-19 PHE, the Medicare program will provide an enhanced payment for eligible inpatient cases that involve use of certain new products with current Food and Drug Administration approval or emergency use authorization to treat COVID-19,” the post read.

According to the CMS document published in the Federal Register memorializing the interim rule, the move specifically centers on the agency’s interpretation of Section 3713 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which established Part B coverage and payments for the COVID vaccine and its administration.

To review the Federal Register post in its entirety, including steps on how to comment and a contact for more information, go online to

For more information about the new add-on payments generally, go to the CMS NCTAP web page at

The global COVID pandemic has now reportedly sickened more than 77 million worldwide, killing 1.7 million, and daily global cases and deaths are currently hovering at or near all-time highs, both domestically and internationally. The U.S. has recorded more than 18 million cases and nearly 325,000 deaths.

Mark Spivey

Mark Spivey is a national correspondent for,, and Auditor Monitor who has been writing and editing material about the federal oversight of American healthcare for more than a decade. He can be reached at

This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles

  • CMS Issues Final Rule on MA, Part D  
    Estimated savings are $75 million over a decade. Federal officials recently announced a series of changes to the Medicare Advantage (MA) and Part D prescription drug programs they hope will save tens of millions of dollars and also allow beneficiaries…
  • The Year That Was 2020
    A former college classmate turned-NBC-TV national news correspondent once told me that he made a career choice—to report the news rather than read the news. Here at RACmonitor we’ve been reporting a considerable amount of news this year with our…
  • Rationing Patient Care in a Pandemic
    Physicians in general are not trained to think this way, but may be forced to do so in the very near future. During the early part of this month, the U.S. has been averaging nearly 200,000 new cases each day,…